Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Instil Bio Appoints Jamie Freedman As Chief Medical Officer

PUBLIC · TILJun 02, 2025•about 1 year ago

Position

Chief Medical Officer

Company

Instil Bio

Jamie Freedman

DallasBiotechnology

Description

Instil Bio, Inc has announced the appointment of Jamie Freedman, MD, PhD, as Chief Medical Officer. Dr Freedman's extensive expertise in oncology drug development will be vital for advancing the company's promising pipeline.

Company Information

Company

Instil Bio

Location

3963 Maple Avenue, Suite 350

Dallas, Texas, United States

About

Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. Instil’s lead asset, AXN-2510, is a novel and differentiated PD-L1xVEGF bispecific antibody in development for the treatment of multiple solid tumor cancers.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Instil Bio's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months